Skip Navigation



Annals of Oncology Advance Access published online on November 3, 2009
Annals of Oncology, doi:10.1093/annonc/mdp517
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mir, O.
Right arrow Articles by Rouzier, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mir, O.
Right arrow Articles by Rouzier, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

Taxanes for breast cancer during pregnancy: a systematic review

The first 10% of the full text of this article appears below.

The co-occurrence of breast cancer and pregnancy is an important issue for the forthcoming years, given the trend for women to postpone childbearing [1]. Although the use of doxorubicin- and epirubicin-based regimens appear quite safe in the second and third trimesters of pregnancy [2, 3], little is known on the safety of taxanes, with only 14 cases found . . . [Full Text of this Article]

disclosure

O. Mir1,2,3,*, P. Berveiller3, F. Goffinet3,4, J.-M. Treluyer2,3, R. Serreau2,3, F. Goldwasser1,3 and R. Rouzier3,5

1 Department of Medical Oncology, Teaching Hospital Cochin
2 Department of Clinical Pharmacology, Clinical Research Unit, Teaching Hospital Cochin, Assistance Publique—Hôpitaux de Paris, University Paris Descartes
3 CALG Group: French Group of ‘Cancers Associés à La Grossesse’
4 Department of Gynaecology and Obstetrics, Teaching Hospital Cochin, Assistance Publique—Hôpitaux de Paris, University Paris Descartes
5 Department of Gynaecology and Obstetrics, Teaching Hospital Tenon, Assistance Publique—Hôpitaux de Paris, University Pierre et Marie Curie, Paris, France

* (E-mail: olivier.mir@cch.aphp.fr)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?